Supreme Court Upholds Manufacturer's Compliance with Price Control Orders — Clarifies Applicability of Revised Prices.

  • 0
Judgement Image
Font size:
Print

Case Note & Summary

This case involved a group of six civil appeals concerning the interpretation of price control orders under the Drugs (Prices Control) Order (DPCO). The appeals arose from conflicting judgments of the Karnataka and Delhi High Courts regarding the applicability of revised prices for pharmaceutical products. The appellant, a manufacturer, contested the enforcement of a price notification issued by the National Pharmaceutical Pricing Authority (NPCA) under DPCO, 1995, which mandated a price reduction for certain formulations. The Karnataka High Court ruled that the revised prices must be applied to all sales within 15 days of notification, while the Delhi High Court adopted a different interpretation. The Supreme Court examined the provisions of DPCO, 1995, particularly paragraphs 14 and 16, and emphasized the obligation of manufacturers to comply with price notifications immediately, allowing a grace period for adjustments. The court rejected the appellant's argument that existing stocks could be sold at pre-notification prices, asserting that such an interpretation would undermine the purpose of price control regulations aimed at consumer protection. The court ultimately upheld the requirement for manufacturers to issue revised price lists and comply with the new prices, reinforcing the principle that consumers should benefit from price reductions as soon as they are notified. The decision clarified the legal obligations of manufacturers under the DPCO and emphasized the importance of equitable pricing in the pharmaceutical industry.

Headnote

A) Administrative Law - Price Control Orders - Applicability of Revised Prices - Drugs (Prices Control) Order, 1995, Paragraphs 14, 16 - The court held that manufacturers must comply with revised prices within 15 days of notification, applying to all existing stocks, not just new batches. This interpretation ensures consumer protection and prevents dual pricing in the market (Paras 49-50).

Subscribe to unlock Headnote Subscribe Now

Issue of Consideration

Whether the prices fixed under the Drugs (Prices Control) Order are applicable to all sales after a specified notification period.

Subscribe to unlock Issue of Consideration Subscribe Now

Final Decision

The Supreme Court upheld the requirement for manufacturers to comply with revised prices within 15 days of notification, applying to all existing stocks. The court clarified that the grace period is for adjustments, not for selling at pre-notification prices.

Law Points

  • Price control
  • Drugs (Prices Control) Order
  • compliance obligations
  • statutory interpretation
  • consumer protection
Subscribe to unlock Law Points Subscribe Now

Case Details

2013 LawText (SC) (12) 43

Civil Appeal No. 1939 of 2004

2014-02-12

R.M. Lodha

S. Ganesh, Indira Jaising

GlaxoSmithKline Pharmaceuticals Limited

Union of India & Ors.

Subscribe to unlock Case Details (Citation, Judge, Date & more) Subscribe Now

Nature of Litigation

Civil appeals concerning price control under pharmaceutical regulations.

Remedy Sought

The appellant sought to challenge the enforcement of price notifications.

Filing Reason

Dispute over the applicability of revised prices to existing stocks.

Previous Decisions

Conflicting judgments from Karnataka and Delhi High Courts.

Issues

Applicability of revised prices under DPCO Interpretation of statutory provisions regarding price notifications

Submissions/Arguments

Appellant argued for pre-notification prices on existing stocks Respondent emphasized immediate compliance with revised prices

Ratio Decidendi

Manufacturers must comply with price notifications immediately, ensuring consumer protection and preventing dual pricing.

Judgment Excerpts

The provisions of the DPC Order are clear that prices should be revised within 15 days even in regard to the formulations which were manufactured prior to the date of notification. The period of 15 days is simply a grace period or cooling period allowed to manufacturers to adjust their business.

Procedural History

The case involved six appeals, four from the Karnataka High Court and two from the Delhi High Court, concerning conflicting interpretations of price control orders.

Acts & Sections

  • Essential Commodities Act, 1955: Section 3
  • Drugs and Cosmetics Act, 1940: Section 3(f)
  • Drugs (Prices Control) Order, 1995: Paragraphs 14, 16
Subscribe to unlock full Legal Analysis Subscribe Now
Related Judgement
Supreme Court Supreme Court Quashes Conviction of Accused in TADA Case Due to Insufficient Evidence Found. The prosecution failed to establish the vital circumstances necessary to connect the accused with the crime, leading to the conclusion that the conviction co...
Related Judgement
High Court Bombay High Court Allows Petition for TDR in DP Road Development Case — Petitioner Entitled to TDR for Roads Developed and Paid For Under DCR 33(7) and 33(8). The court held that the Petitioner is entitled to Transferable Development Rights (TDR) i...